Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin - PubMed (original) (raw)
Comparative Study
. 1997 Dec 6;350(9092):1670-3.
doi: 10.1016/S0140-6736(97)07324-8.
Affiliations
- PMID: 9400512
- DOI: 10.1016/S0140-6736(97)07324-8
Comparative Study
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
K Hiramatsu et al. Lancet. 1997.
Abstract
Background: Since the discovery of the vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 (minimum inhibitory concentration [MIC] 8 mg/L), there has been concern about the potential spread of such strains throughout Japanese hospitals. Two important questions need to be answered: (1) what is the prevalence of VRSA, and (2) by what mechanism does vancomycin resistance occur.
Methods: The vancomycin susceptibilities of three methicillin-resistant S aureus (MRSA) strains (Mu50, Mu3, and H1) and the methicillin-susceptible S aureus type strain FDA209P were compared by MIC determinations and population analysis. Mu3 (MIC 3 mg/L) was isolated from the sputum of a patient with pneumonia after surgery who had failed vancomycin therapy. H1 (MIC 2 mg/L), which is a representative vancomycin-susceptible MRSA strain, was isolated from a patient with pneumonia who responded favourably to vancomycin therapy. Subclones of Mu3 with increased resistance against vancomycin were selected with serial concentrations of vancomycin and their MICs were determined. The prevalence of VRSA and Mu3-like strains in Japanese hospitals was estimated by population analysis from 1149 clinical MRSA isolates obtained from 203 hospitals throughout Japan. The genetic traits of the Mu3 and Mu50 strains were compared with clonotypes of MRSA from around the world.
Findings: Mu3 and Mu50 had an identical pulsed-field gel electrophoresis banding pattern. When grown in a drug-free medium, Mu3 produced subpopulation of cells with varying degrees of vancomycin resistance, thus demonstrating natural heterogeneity, or variability, in susceptibility to vancomycin. In the presence of vancomycin, Mu3 produced subclones with resistance roughly proportional to the concentrations of vancomycin used. Selection of Mu3 with 8 mg/L or more of vancomycin gave rise to subclones with vancomycin resistance equal to that of Mu50 (MIC 8 mg/L) at a frequency of 1/1,000,000. During screening of Japanese MRSA strains, no strain of VRSA additional to Mu50 was found. The prevalence of MRSA isolates heterogeneously resistant to vancomycin was 20% in Juntendo University Hospital, 9.3% in the other seven university hospitals, and 1.3% in non-university hospitals or clinics.
Interpretation: Heterogeneously resistant VRSA is a preliminary stage that allows development into VRSA upon exposure to vancomycin. Heterogeneously resistant VRSA was found in hospitals throughout Japan. This finding could explain, at least partly, the frequent therapeutic failure of MRSA infection with vancomycin in Japan.
Comment in
- Vancomycin-resistant Staphylococcus aureus: apocalypse now?
Tabaqchali S. Tabaqchali S. Lancet. 1997 Dec 6;350(9092):1644-5. doi: 10.1016/S0140-6736(05)64269-9. Lancet. 1997. PMID: 9400504 No abstract available. - Vancomycin-resistant Staphylococcus aureus.
Lessing MP, Raftery MJ. Lessing MP, et al. Lancet. 1998 Feb 21;351(9102):601-2. doi: 10.1016/s0140-6736(05)78596-2. Lancet. 1998. PMID: 9492813 No abstract available. - Vancomycin-resistant Staphylococcus aureus.
Howe RA, Bowker KE, Walsh TR, Feest TG, MacGowan AP. Howe RA, et al. Lancet. 1998 Feb 21;351(9102):602. doi: 10.1016/S0140-6736(05)78597-4. Lancet. 1998. PMID: 9492814 No abstract available. - First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.
Ploy MC, Grélaud C, Martin C, de Lumley L, Denis F. Ploy MC, et al. Lancet. 1998 Apr 18;351(9110):1212. doi: 10.1016/s0140-6736(05)79166-2. Lancet. 1998. PMID: 9643727 No abstract available.
Similar articles
- Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.
Ike Y, Arakawa Y, Ma X, Tatewaki K, Nagasawa M, Tomita H, Tanimoto K, Fujimoto S. Ike Y, et al. J Clin Microbiol. 2001 Dec;39(12):4445-51. doi: 10.1128/JCM.39.12.4445-4451.2001. J Clin Microbiol. 2001. PMID: 11724859 Free PMC article. - Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. Hanaki H, et al. J Antimicrob Chemother. 1998 Aug;42(2):199-209. doi: 10.1093/jac/42.2.199. J Antimicrob Chemother. 1998. PMID: 9738837 - Detection Methods of Glycopeptide-Resistant Staphylococcus aureus I : Susceptibility Testing.
Hanaki H, Hiramatsu K. Hanaki H, et al. Methods Mol Med. 2001;48:85-91. doi: 10.1385/1-59259-077-2:85. Methods Mol Med. 2001. PMID: 21374408 - [Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Inaba Y, Hiramatsu K. Inaba Y, et al. Nihon Rinsho. 1998 Oct;56(10):2699-705. Nihon Rinsho. 1998. PMID: 9796340 Review. Japanese. - [Clinical relevance of hetero-VRSA in surgical infections].
Okii K, Takesue Y, Yokoyama T. Okii K, et al. Nihon Rinsho. 2001 Apr;59(4):728-32. Nihon Rinsho. 2001. PMID: 11304997 Review. Japanese.
Cited by
- Single-cell phenotypic profiling and backtracing exposes and predicts clinically relevant subpopulations in isogenic Staphylococcus aureus communities.
Hira J, Singh B, Halder T, Mahmutovic A, Ajayi C, Sekh AA, Hegstad K, Johannessen M, Lentz CS. Hira J, et al. Commun Biol. 2024 Oct 1;7(1):1228. doi: 10.1038/s42003-024-06894-z. Commun Biol. 2024. PMID: 39354092 Free PMC article. - Synthesis, Characterization and Application of Advanced Antimicrobial Electrospun Polymers.
Somogyi Škoc M, Meštrović E, Mouthuy PA, Rezić I. Somogyi Škoc M, et al. Polymers (Basel). 2024 Aug 28;16(17):2443. doi: 10.3390/polym16172443. Polymers (Basel). 2024. PMID: 39274076 Free PMC article. - Diagnostic value of BHI-V4 for heterogeneous and vancomycin-intermediate Staphylococcus aureus isolates: a systematic review and meta-analysis.
Cheng X, Zhou J, Yuan F, Ma J, Guo S, Su J. Cheng X, et al. BMC Infect Dis. 2024 May 14;24(1):494. doi: 10.1186/s12879-024-09274-4. BMC Infect Dis. 2024. PMID: 38745289 Free PMC article. - Rapid eradication of vancomycin and methicillin-resistant Staphylococcus aureus by MDP1 antimicrobial peptide coated on photocrosslinkable chitosan hydrogel: in vitro antibacterial and in silico molecular docking studies.
Ekhtiari-Sadegh S, Samani S, Barneh F, Dashtbin S, Shokrgozar MA, Pooshang Bagheri K. Ekhtiari-Sadegh S, et al. Front Bioeng Biotechnol. 2024 Apr 11;12:1385001. doi: 10.3389/fbioe.2024.1385001. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38681961 Free PMC article. - Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance.
Levin BR, Berryhill BA, Gil-Gil T, Manuel JA, Smith AP, Choby JE, Andersson DI, Weiss DS, Baquero F. Levin BR, et al. Proc Natl Acad Sci U S A. 2024 Apr 16;121(16):e2318600121. doi: 10.1073/pnas.2318600121. Epub 2024 Apr 8. Proc Natl Acad Sci U S A. 2024. PMID: 38588431 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases